104 related articles for article (PubMed ID: 22364731)
1. Is there a general autoantibody signature for cancer?
Ludwig N; Keller A; Leidinger P; Harz C; Backes C; Lenhof HP; Meese E
Eur J Cancer; 2012 Oct; 48(15):2451-61. PubMed ID: 22364731
[TBL] [Abstract][Full Text] [Related]
2. Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H
Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
Bradford TJ; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(3):237-42. PubMed ID: 16678056
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
Fernández Madrid F
Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
[TBL] [Abstract][Full Text] [Related]
5. Profiling tumor-associated autoantibodies for the detection of colon cancer.
Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
[TBL] [Abstract][Full Text] [Related]
6. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
[TBL] [Abstract][Full Text] [Related]
7. Serologic autoantibodies as diagnostic cancer biomarkers--a review.
Zaenker P; Ziman MR
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2161-81. PubMed ID: 24057574
[TBL] [Abstract][Full Text] [Related]
8. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
[TBL] [Abstract][Full Text] [Related]
9. Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.
Luo X; Lu F; Wang HL; Wang N; Li WH; Guo N; Wang HX; Xia Q
Biochem Biophys Res Commun; 2012 Apr; 420(4):704-9. PubMed ID: 22310721
[TBL] [Abstract][Full Text] [Related]
10. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.
Tong YQ; Zhang ZJ; Liu B; Huang J; Liu H; Liu Y; Guo FJ; Zhou GH; Xie PL; Li YH; Zuo CH; Hu JY; Li GC
Proteomics; 2008 Aug; 8(15):3185-93. PubMed ID: 18654982
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of dihydrolipoamide dehydrogenase as a target of autoantibodies in patients with endometrial cancer.
Yoneyama K; Shibata R; Igarashi A; Kojima S; Kodani Y; Nagata K; Kurose K; Kawase R; Takeshita T; Hattori S
Anticancer Res; 2014 Sep; 34(9):5021-7. PubMed ID: 25202086
[TBL] [Abstract][Full Text] [Related]
13. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody profiles as biomarkers of breast cancer.
Tabernero MD; Lv LL; Anderson KS
Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
[TBL] [Abstract][Full Text] [Related]
15. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.
Grus FH; Joachim SC; Bruns K; Lackner KJ; Pfeiffer N; Wax MB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):968-76. PubMed ID: 16505031
[TBL] [Abstract][Full Text] [Related]
16. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer.
Wu L; Chang W; Zhao J; Yu Y; Tan X; Su T; Zhao L; Huang S; Liu S; Cao G
Clin Cancer Res; 2010 Jul; 16(14):3760-8. PubMed ID: 20501620
[TBL] [Abstract][Full Text] [Related]
17. Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing.
Li WH; Zhao J; Li HY; Liu H; Li AL; Wang HX; Wang J; He K; Liang B; Yu M; Shen BF; Zhang XM
Proteomics; 2006 Sep; 6(17):4781-9. PubMed ID: 16878294
[TBL] [Abstract][Full Text] [Related]
18. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in cancer: prognostic biomarkers and immune activation.
Järås K; Anderson K
Expert Rev Proteomics; 2011 Oct; 8(5):577-89. PubMed ID: 21999829
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.
Schmitt J; Heisel S; Keller A; Leidinger P; Ludwig N; Habel N; Furtwängler R; Nourkami-Tutdibi N; Wegert J; Grundy P; Gessler M; Graf N; Lenhof HP; Meese E
Int J Cancer; 2012 Aug; 131(3):673-82. PubMed ID: 21913182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
